Not applicableStudy completedNCT00420290
What this trial is testing
Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
Who this might be right for
End Stage Renal Disease
Vanderbilt University 31
Showing 20 of 0 results